Abstract: IoT device identification is often used as the first line of defense. However, it is challenging due to the acquisition of IoT as a business by the existing vendors of traditional computing ...

Merus (MRUS) announced interim clinical data as of a July 29, 2025 data cutoff from the ongoing phase 2 trial of the bispecific antibody petosemtamab in combination with standard of care ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Coarse-grained (CG) models provide an effective route to reduce the complexity of ...

ZUG, Switzerland, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet ...

Abstract: Passivity-based control (PBC) is a powerful control strategy, excelling in stability through its energy-based framework. It is regarded as an effective method for enhancing the dependability ...

PLAINSBORO, N.J., and BAGSVÆRD, Denmark, Oct. 20, 2025 /PRNewswire/ -- Novo Nordisk today announced new data on the investigational oral semaglutide 25 mg will be among 23 abstracts to be presented at ...

Moderna Inc. (NASDAQ:MRNA) is one of the best high volume stocks to buy according to Wall Street analysts. On October 13, Moderna announced that promising clinical, safety, and translational data from ...

US investors put more than $85 billion to work in long-term funds in September, the largest monthly inflow of 2025. Investors sought safe havens, such as less-volatile taxable-bond categories and ...

AUSTIN, Texas, Oct. 14, 2025 /PRNewswire/ -- Genprex, Inc. (GNPX) ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for ...